Micropaque Ct (Barium Sulfate)

Barium sulfate works by providing a dense, radiopaque coating of the gastrointestinal mucosa. Its high atomic number strongly scatters X‑ray photons, creating a clear silhouette of the GI tract on radiographs. This contrast enables detailed imaging of structures such as the esophagus, stomach, small intestine, colon, and rectum.

The dose of Micropaque Ct is individualized and set by the prescribing physician based on the specific imaging study, patient age, weight, and clinical condition. No standard dosing regimen is provided publicly; healthcare professionals calculate the appropriate volume to achieve optimal contrast while minimizing discomfort.

Safety data for Micropaque Ct in pregnancy and lactation are limited. Because barium sulfate is not absorbed systemically in significant amounts, it is generally considered low risk, but it should only be used when clearly indicated and after careful risk‑benefit assessment by the treating physician.

To place an order, submit an enquiry on the Micropaque Ct product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, requesting trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Micropaque Ct, containing barium sulfate, offers superior radiopacity for gastrointestinal imaging compared with iodine‑based agents, which are better suited for vascular studies. Barium provides longer-lasting coating of the GI lumen and is less likely to cause allergic reactions, though it is contraindicated in cases of suspected perforation, where water‑soluble iodinated agents are preferred.

Micropaque Ct should be stored at room temperature, ideally below 25 °C, in its original sealed container. Protect the product from moisture, direct sunlight, and extreme temperatures. Ensure the suspension is well‑mixed before administration, and avoid contamination by using aseptic techniques when drawing the required volume.

Micropaque Ct is administered orally for upper GI studies or rectally for lower GI examinations. The prescribed volume is mixed with a suitable liquid, shaken gently to ensure uniform suspension, and then ingested or introduced via a catheter into the colon. Administration is performed under the supervision of qualified radiology personnel.

The most serious risks include severe allergic reactions such as anaphylaxis, aspiration pneumonia if the suspension enters the airway, and gastrointestinal complications like obstruction or perforation. In patients with compromised renal function, there is a potential for acute kidney injury, especially when large volumes are used without adequate hydration.

Micropaque Ct should be avoided in patients with known hypersensitivity to barium sulfate, suspected or confirmed gastrointestinal perforation, severe constipation, or bowel obstruction. Caution is also advised for individuals with impaired renal function, severe dehydration, or those unable to cooperate with the administration procedure.